Live Breaking News & Updates on Scientific Panel For Health

Stay updated with breaking news from Scientific panel for health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Transgene's Combined General Meeting of May 25, 2022

Transgene’s Combined General Meeting of May 25, 2022 Strasbourg, France, May 25, 2022, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonth. ....

United States , Illkirch Graffenstaden , Laurence Espinasse , Philippe Archinard , Sandrine Flory , Ben Brahim , Alessandro Riva , Marie Landel , European Organization For Research , European Society Of Medical Oncology , Cell Gene Therapy At Gilead Sciences , Ichnos Sciences , Global Head Of Oncology Development , European Commission Conticanet , Claude Bernard University In Lyon , French National Cancer Institute , Affairs At Novartis Pharmaceuticals , Life Sciences , French Sarcoma Group , University Of Milan , Scientific Panel For Health , French National Academy Of Medicine , Combined General Meeting , Combined Ordinary , Extraordinary General Meeting , Hedi Ben Brahim ,

Transgene's Combined General Meeting of May 25, 2022

Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard ....

United States , Illkirch Graffenstaden , Rheinland Pfalz , Lucie Larguier , Sandrine Flory , Ben Brahim , Alessandro Riva , Marie Landel , Sylvie Berrebi , Laurence Espinasse , Philippe Archinard , Transgene Euronext , Centre Sud Montpellier , European Society Of Medical Oncology , European Commission Conticanet , Claude Bernard University In Lyon , French National Cancer Institute , Scientific Panel For Health , French National Academy Of Medicine , European Organization For Research , Cell Gene Therapy At Gilead Sciences , Global Head Of Oncology Development , Ichnos Sciences , Ernst Young , Corporate Communications , Affairs At Novartis Pharmaceuticals ,